These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis. Aurbek N, Thiermann H, Eyer F, Eyer P, Worek F. Toxicology; 2009 May 17; 259(3):133-9. PubMed ID: 19428953 [Abstract] [Full Text] [Related]
10. Reactivation kinetics of 31 structurally different bispyridinium oximes with organophosphate-inhibited human butyrylcholinesterase. Horn G, Wille T, Musilek K, Kuca K, Thiermann H, Worek F. Arch Toxicol; 2015 Mar 17; 89(3):405-14. PubMed ID: 24912784 [Abstract] [Full Text] [Related]
11. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study. Costa MD, Freitas ML, Soares FA, Carratu VS, Brandão R. Toxicol In Vitro; 2011 Dec 17; 25(8):2120-3. PubMed ID: 21983245 [Abstract] [Full Text] [Related]
12. Pyridoxal oxime derivative potency to reactivate cholinesterases inhibited by organophosphorus compounds. Bušić V, Katalinić M, Šinko G, Kovarik Z, Gašo-Sokač D. Toxicol Lett; 2016 Nov 16; 262():114-122. PubMed ID: 27693733 [Abstract] [Full Text] [Related]
13. Non-quaternary oximes detoxify nerve agents and reactivate nerve agent-inhibited human butyrylcholinesterase. Amitai G, Plotnikov A, Chapman S, Lazar S, Gez R, Loewenthal D, Shurrush KA, Cohen G, Solmesky LJ, Barr H, Russell AJ. Commun Biol; 2021 May 14; 4(1):573. PubMed ID: 33990679 [Abstract] [Full Text] [Related]